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Monday, February 9, 2015 265aFlecainide, a dual sodium channel and RyR2 Ca release channel blocker
classified as a class Ic antiarrhythmic agent, has been used to suppress ventric-
ular arrhythmias caused by spontaneous Ca release from the sarcoplasmic
reticulum in animal models and humans. Since flecainide exhibits much
lower antiarrhythmic potency in isolated cells and single RyR2 in vitro
than in vivo, whether RyR2 block contributes to its antiarrhythmic
mechanism of action has remained controversial. Here we test the hypothesis
that loss of Calmodulin (CaM), a physiological binding partner of RyR2 Ca
release channels, is responsible for the discrepancy of in vivo and in vitro
results.
Using single channels isolated from sheep hearts and incorporated into lipid
bilayers, we constructed concentration-response curves of flecainide in the
presence and absence of physiological CaM concentrations (100nM). Pres-
ence of CaM potentiated the action of flecainide on single RyR2 channels,
with 3-fold increase in potency (IC50 flecainide¼ 8.6 mM vs. IC50 flecainide
þ CaM¼ 2.8 mM) and a modest increase in Emax. We next tested flecainide
in permeabilized ventricular myocytes isolated from calsequestrin knockout
mice, an established genetic model of Ca-release triggered ventricular
arrhythmia, and from C57Bl6 wild-type mice. Addition of 100 nM CaM
doubled both the potency (from 3 mM to 1.4 mM) and efficacy (from 40%
to 80% inhibition) of Ca wave suppression by flecainide in calsequestrin
KO cells. Moreover, in wild type cells, flecainide had no effect in absence
of CaM, whereas in the presence of CaM, flecainide exhibited a modest effect
in waves suppression with 25% inhibition of Ca waves and IC50 ¼ 1 mM.
Thus, the presence of physiological concentrations of Calmodulin is critical
for flecainide’s block of RyR2 channels and therefore its antiarrhythmic
effect.Excitation-Contraction Coupling I
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Anthracyclines are highly effective chemotherapeutic agents whose use is
limited due to the onset of side effects including potentially fatal cardiotoxic-
ity. The exact molecular mechanism(s) of the cardiotoxicity are unknown,
although two prominent hypotheses involve oxidative stress-mediated cell
damage due to reactive oxygen species (ROS) production, and
anthracycline-induced dysfunction of cardiomyocyte calcium signaling path-
ways. Our previous data has illustrated that the anthracycline doxorubicin
modifies RyR2 and SERCA2A activity by binding to the proteins and also
via thiol oxidation to disrupt SR calcium handling. Calsequestrin (CSQ2), a
calcium binding protein and RyR2 regulator, has been identified as a third
drug-binding target. Our overall aims were to further explore doxorubicin-
induced ROS production and assess any functional consequences of doxoru-
bicin binding to CSQ2.
Firstly, we investigated whether in vitro anthracycline treatment generated the
endogenous ROS superoxide. We used cardiomyocytes from mitochondria-
targeted cpYFP transgenic mice to assess stochastic and quantal bursts of
superoxide produced within the mitochondria matrix (superoxide flashes).
Our results show that increasing doxorubicin concentration from nM to low
uM induces a concentration and time-dependent increase in superoxide flash
frequency and amplitude, indicating that superoxide flash activity contributes
to doxorubicin-induced ROS production.
Secondly, we explored the effects of doxorubicin on CSQ2. Acute doxorubicin
treatment resulted in dissociation of CSQ2 from RyR2. In addition, doxorubicin
binding to RyR2 and CSQ2 disrupted RyR2 responsiveness to the range of
luminal calcium experienced in a cell cycle. Both mechanisms would result
in dysregulated RyR2 calcium release.
Taken together, this data extends our knowledge of the complexity of
doxorubicin-induced cardiomyocyte damage. We propose that doxorubicin
alters calcium homeostasis by targeting RyR2, SERCA2A and CSQ2 directly,
by inducing thiol modification on RyR2 and SERCA2A and by producing
mitochondrial superoxide, all which could contribute to the often-fatal cardi-
otoxicity.1339-Pos Board B290
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The sarcolemmal Naþ/Ca2þ exchanger (NCX) is the primary mechanism for
extruding cytosolic Ca2þ and maintaining Ca2þ homeostasis in cardiomyo-
cytes. NCX activity is allosterically regulated by intracellular Ca2þ concentra-
tion ([Ca2þ]i) via NCX Ca
2þ-binding domains (CBD12). The kinetic and
equilibrium binding properties of CBD12 and the dynamics of NCX activation
have been intensively studied and characterized in Ca2þ binding assays and gi-
ant excised patch voltage clamp experiments. The physiological role of NCX
and the dynamics of its regulation by [Ca2þ]i in intact cardiomyocytes remains
poorly understood. Many previous mathematical models have been formulated
to describe NCX kinetics and its Ca2þ-dependent regulation. However, these
models lack a description of the dynamics of Ca2þ-dependent allosteric regu-
lation. Here we develop a new mechanistic NCX model which incorporates
physiological Ca2þ-binding of CBD12 and predicts features of the time-
dependent regulation of NCX function. We show that NCX activation occurs
slowly (~ seconds) in response to a moderate step increase of [Ca2þ]i
(< 1mM),but exhibits nearly instantaneous activation followed by a slower, sec-
ondary phase in response to a [Ca2þ]i step increase of larger magnitude
(> 1mM). This property enables NCX to differentially sense and respond to dy-
namic Ca2þ signals within specific subcellular compartments in cardiac myo-
cytes (e.g. dyadic cleft, submembrane space, bulk cytosol) and may play an
important role in the regulation of excitation-contraction coupling under both
physiological and pathological conditions. We incorporate this mechanistic
NCX model into a stochastic, local control model of the canine ventricular my-
ocyte and show that over-expression of NCX can be an independent proarrhyth-
mic factor that leads to generation of early-afterdepolarizations.
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Membrane ionic currents (Im)measurement from cardiac multicellular prepara-
tions has been an obstacle in the understanding of cardiac excitability. The role
of Na-Ca exchanger (NCX) in excitation-contraction coupling has remained
elusive greatly due to this difficulty. Here we used loose patch photolysis to
measure Im in intact-perfused whole hearts, to investigate the impact of the
Ca2þ released from the sarcoplasmic reticulum (SR) on the epicardial action
potential (AP). We had previously observed that the epicardial mouse AP, ex-
hibits a phase 2 that is reduced by ryanodine (Ry) and thapsigargin (Tg). To
investigate if Im is directly activated by the SR Ca
2þ release during the phase
2, nifedipine photolysis was used. We found a late-inward current (Ilate) that
was abolished by Ry and Tg. To determine if the NCX was responsible for Ilate,
the NCX blocker SEA0400 was used. SEA0400 had a similar effect on AP
phase 2 as that observed with Ry and Tg. To further test if the SEA0400 effect
was the result of impairing the Ca2þ removal, intracellular Ca2þ transients were
studied. Consistent with NCX blockade, SEA0400 increased the amplitude of
the Ca2þ transients. In addition, to determine if NCX current can be activated
during diastole, intracellular NP-EGTA was photolyzed to activate a Ca2þ
dependent conductance. Our results revealed a diastolic inward current that
increased with the photolysis extent and that was partially blocked by
SEA0400. Our data demonstrate that during an epicardial AP there is a late
influx of Naþ mediated by Ca2þ activation of NCX and that this exchanger,
can also be activated by Ca2þ during diastole. This finding is relevant because
the Ca2þ activation of this transporter is likely to be involved in the genesis of
pro-arrhythmogenic conditions.
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Calmodulin (CALM) is an important protein involved in numerous signaling
processes, acting through induced conformational changes in response to local
